113 related articles for article (PubMed ID: 27658340)
21. Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial.
Zhang X; Zhang H; Chen L; Wang M; Xi J; Liu X; Xie M; Li D; Gulati ES; Gong S; Wang H
Trials; 2018 Sep; 19(1):476. PubMed ID: 30185214
[TBL] [Abstract][Full Text] [Related]
22. Combination therapy with arsenic trioxide, all-trans retinoic acid, and chemotherapy in acute promyelocytic leukemia patients with various relapse risks.
Huang H; Qin Y; Xu R; You X; Teng R; Yang L; Xu M; Liu H
Leuk Res; 2012 Jul; 36(7):841-5. PubMed ID: 22534100
[TBL] [Abstract][Full Text] [Related]
23. Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experience.
Kelaidi C; Chevret S; De Botton S; Raffoux E; Guerci A; Thomas X; Pigneux A; Lamy T; Rigal-Huguet F; Meyer-Monard S; Chevallier P; Maloisel F; Deconinck E; Ferrant A; Fegueux N; Ifrah N; Sanz M; Dombret H; Fenaux P; Adès L
J Clin Oncol; 2009 Jun; 27(16):2668-76. PubMed ID: 19414681
[TBL] [Abstract][Full Text] [Related]
24. Prolonged treatment with arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) for relapsed acute promyelocytic leukemia previously treated with ATRA and chemotherapy.
Cicconi L; Breccia M; Franceschini L; Latagliata R; Molica M; Divona M; Diverio D; Rizzo M; Ottone T; Iaccarino L; Alfonso V; Foa R; Voso MT; Lo-Coco F
Ann Hematol; 2018 Oct; 97(10):1797-1802. PubMed ID: 29951912
[TBL] [Abstract][Full Text] [Related]
25. Frontline therapy of acute promyelocytic leukemia: Randomized comparison of ATRA and intensified chemotherapy versus ATRA and anthracyclines.
Lengfelder E; Görlich D; Nowak D; Spiekermann K; Haferlach C; Krug U; Kreuzer KA; Braess J; Schliemann C; Lindemann HW; Horst HA; Schiel X; Flasshove M; Hecht A; Schnittger S; Schneider S; Wörmann B; Hofmann WK; Berdel WE; Bormann E; Sauerland C; Büchner T; Hiddemann W;
Eur J Haematol; 2018 Feb; 100(2):154-162. PubMed ID: 29114972
[TBL] [Abstract][Full Text] [Related]
26. Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto.
Specchia G; Lo Coco F; Vignetti M; Avvisati G; Fazi P; Albano F; Di Raimondo F; Martino B; Ferrara F; Selleri C; Liso V; Mandelli F
J Clin Oncol; 2001 Oct; 19(20):4023-8. PubMed ID: 11600603
[TBL] [Abstract][Full Text] [Related]
27. How to manage acute promyelocytic leukemia.
Mi JQ; Li JM; Shen ZX; Chen SJ; Chen Z
Leukemia; 2012 Aug; 26(8):1743-51. PubMed ID: 22422168
[TBL] [Abstract][Full Text] [Related]
28. Treatment concepts of acute promyelocytic leukemia.
Lengfelder E; Saussele S; Weisser A; Büchner T; Hehlmann R
Crit Rev Oncol Hematol; 2005 Nov; 56(2):261-74. PubMed ID: 16236522
[TBL] [Abstract][Full Text] [Related]
29. Advances in the treatment of relapsed acute promyelocytic leukemia.
Douer D
Acta Haematol; 2002; 107(1):1-17. PubMed ID: 11818666
[TBL] [Abstract][Full Text] [Related]
30. Treatment of an acute promyelocytic leukemia relapse using arsenic trioxide and all-trans-retinoic in a 6-year-old child.
Rock N; Mattiello V; Judas C; Huezo-Diaz P; Bourquin JP; Gumy-Pause F; Ansari M
Pediatr Hematol Oncol; 2014 Mar; 31(2):143-8. PubMed ID: 24498972
[TBL] [Abstract][Full Text] [Related]
31. [Role of retinoic acid in the treatment of acute promyelocytic leukemia].
Gutiérrez de Guzmán J; Kantarjian H
Sangre (Barc); 1993 Oct; 38(5):375-8. PubMed ID: 8140499
[No Abstract] [Full Text] [Related]
32. Recurrent acute promyelocytic leukemia presenting as a sacral nerve root mass.
Kesari S; Drappatz J; Akar S; Vergilio JA; Wen PY; Soiffer RJ; Stone RM; Deangelo DJ
J Clin Oncol; 2008 Jul; 26(19):3279-81. PubMed ID: 18591563
[No Abstract] [Full Text] [Related]
33. t(15;17) hypergranular acute promyelocytic leukemia (M3) developing into a t(3;6) M3 without t(15;17) at relapse.
Desangles F; Vilain E; Arborio M; De Revel T; Flandrin G
Leuk Lymphoma; 1995 Sep; 19(1-2):185-8. PubMed ID: 8574167
[TBL] [Abstract][Full Text] [Related]
34. Causes for refusal or abandonment during treatment of pediatric acute promyelocytic leukemia.
Li EQ; Jin RM
Leuk Res; 2012 Sep; 36(9):e193-4. PubMed ID: 22727511
[No Abstract] [Full Text] [Related]
35. All-transretinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia.
Al Bahar S; Pandita R; Bavishi K; Kreze O
Indian J Cancer; 2004; 41(3):125-8. PubMed ID: 15472411
[TBL] [Abstract][Full Text] [Related]
36. Extramedullary involvement in patients with acute promyelocytic leukemia: a report of seven cases.
Liso V; Specchia G; Pogliani EM; Palumbo G; Mininni D; Rossi V; Teruzzi E; Mestice A; Coppi MR; Biondi A
Cancer; 1998 Oct; 83(8):1522-8. PubMed ID: 9781945
[TBL] [Abstract][Full Text] [Related]
37. Modern approaches to treating acute promyelocytic leukemia.
Sanz MA; Lo-Coco F
J Clin Oncol; 2011 Feb; 29(5):495-503. PubMed ID: 21220600
[TBL] [Abstract][Full Text] [Related]
38. Case of pediatric acute promyelocytic leukemia presenting as extramedullary tumor of the mandible.
Yamashita Y; Isomura N; Hamasaki Y; Goto M
Head Neck; 2013 Oct; 35(10):E310-3. PubMed ID: 22972688
[TBL] [Abstract][Full Text] [Related]
39. Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.
Jurcic JG; Caron PC; Miller WH; Yao TJ; Maslak P; Finn RD; Larson SM; Warrell RP; Scheinberg DA
Leukemia; 1995 Feb; 9(2):244-8. PubMed ID: 7869759
[TBL] [Abstract][Full Text] [Related]
40. [Long-term results of combined treatment of acute promyelocytic leukemia in children and adolescents with gene therapy].
Samochatova EV; Maschan AA; Aleĭnikova OV; Bespalova AV; Baĭdil'dina DD; Dubrovina ME; Fleĭshman EV; Nasedkina TV; Rumiantsev SA; Rumiantsev AG
Ter Arkh; 2007; 79(7):26-30. PubMed ID: 17802786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
